EUMENTIS THERAPEUTICS, INC.

Profile

Company Names

EUMENTIS THERAPEUTICS, INC.

Addresses

508 DUDLEY ROAD, SUITE 105, NEWTON, MA 02459

Phone Numbers

6174133020

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$7,265,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2022-04-13 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
2
2021-08-16 
$765,000.00 
$2,000,000.00 
$1,235,000.00 
Debt 
1
2018-08-14 
$1,500,000.00 
$3,300,000.00 
$1,800,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARYANN 
 
BRYLA 
DIRECTOR
EUMENTIS THERAPEUTICS, INC.
AMAR 
 
KAPUR 
DIRECTOR
EUMENTIS THERAPEUTICS, INC.
JAMES 
 
LARRICK 
DIRECTOR
THERON PHARMACEUTICALS, INC.   |  TIGERCAT PHARMA, INC.   |  EUMENTIS THERAPEUTICS, INC.   |  MASCOMA MUTUAL FINANCIAL SERVICES CORP   |  FBOL BANCSHARES, INC.
RANDALL 
 
MARSHALL 
EXECUTIVE OFFICER
ARTARA THERAPEUTICS, INC.   |  EUMENTIS THERAPEUTICS, INC.
KIM 
 
PATRICK 
DIRECTOR
EUMENTIS THERAPEUTICS, INC.
ANDREW 
 
PEARLMAN 
DIRECTOR
SPRINGCOIN, INC.   |  EUMENTIS THERAPEUTICS, INC.
MARK 
 
TEPPER 
EXECUTIVE OFFICER, DIRECTOR
JB THERAPEUTICS, INC.   |  PRIMATOPE THERAPEUTICS, INC.   |  CORBUS PHARMACEUTICALS HOLDINGS, INC.   |  RETE PAY INC.   |  EUMENTIS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-06-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2021-08-16 
2022-04-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-04-13 
2020-09-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#